OCM
LSBPW

Ovata Capital Management’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Ovata Capital Management’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-150,000
Closed -$14.8K – 49
2024
Q4 		$14.8K Hold
150,000
– – 0.01% 33
2024
Q3 		$9.91K Buy
+150,000
New +$9.46K ﹤0.01% 33

Other funds holding LSBPW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
AC
Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $864M AUM 906.77% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $157M AUM 29.28% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Ovata Capital Management's LSBPW Position: Q1 2025 in Review

Ovata Capital Management sold out of LakeShore Biopharma Warrants (LSBPW) in Q1 2025, closing a stake of 150,000 shares — an estimated $14.8K sold.

Ovata Capital Management first reported a position in LSBPW in Q3 2024 and held it in 2 quarters. The position peaked at $14.8K in Q4 2024. 18 funds tracked by Wall St. Rank hold LSBPW as of Q1 2025.

  • Ovata Capital Management reported no remaining LakeShore Biopharma Warrants position as of Q1 2025 after selling out during the quarter.
  • Ovata Capital Management sold 150,000 LakeShore Biopharma Warrants shares in Q1 2025, an estimated $14.8K.
  • Ovata Capital Management first reported a position in LakeShore Biopharma Warrants in Q3 2024 and held it in 2 quarters.
  • Ovata Capital Management's LakeShore Biopharma Warrants position peaked at $14.8K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q1 2025.

Based on Ovata Capital Management's 13F filing for Q1 2025, filed 12 May 2025.